Lantheus Alpha Therapy, LLC bought CATX
March 6, 2024 · Form 4 insider transaction
Lantheus Alpha Therapy, LLC bought 60,431,039 shares of Perspective Therapeutics, Inc. at $0.95 per share, a transaction worth $57.41M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,431,039
Price
$0.95
Total value
$57.41M
InsiderLantheus Alpha Therapy, LLC
Role10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 6, 2024
Filing dateMarch 8, 2024
Shares owned after116,773,394
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership.